The Gür fibromyalgia model: a clinically operational framework for phenotype-informed, sequence-sensitive multimodal care
Fibromyalgia affects approximately 2%–4% of adults and many patients obtain less than clinically meaningful benefit from any single pharmacological treatment, underscoring the need for a practical method of prioritizing multimodal care. This purposive narrative, hypothesis-generating review introduces the Gür Fibromyalgia Model (GFM), an expert-derived and currently unvalidated framework that organizes fibromyalgia around five interacting domains:…